Folic Acid vs Methylfolate in Pregnancy
What’s the Difference, and What Should You Choose?
If you’ve ever researched folate (aka Vitamin B9) before or during pregnancy, you’ll know it’s one of the most debated topics in prenatal nutrition. Some sources insist folic acid is the only right choice; others argue for methylfolate. For expectant parents and people planning a pregnancy and trying to choose the best prenatal, this conflicting information can be stressful, confusing, and overwhelming.
You might have heard:
-
“You need folic acid before you even get pregnant”
-
“Methylfolate is better if you have MTHFR”
-
“Folic acid is synthetic and hard to absorb”
-
“Some prenatals don’t contain folic acid at all”
What we do know is that folate is one of the most critical nutrients for reproductive health. From preparing the body for conception to supporting early foetal development, folate is one nutrient that deserves a clear, evidence-based understanding, not half-truths or bias.
In this article, we’ll look at what the science actually shows about the two most prevalent folate forms found in prenatal supplements: folic acid and methylfolate. We address what public health authorities recommend, and where the evidence is strong, as well as where it is limited, so you can make an informed choice, not just follow the loudest voice online.
What is folate?
Folate is the umbrella term for vitamin B9, a nutrient involved in DNA synthesis, cell division and normal growth. Or in simple terms, it helps your body make new cells and supports healthy growth (which is especially important in early pregnancy).
During early pregnancy, folate plays a critical role in the formation of the neural tube, which later becomes the baby’s brain and spinal cord. This is why it’s recommended to start taking folate BEFORE conception, not after a positive test.
Folate comes in different forms, including:
-
Naturally in foods (leafy greens, legumes, citrus, eggs)
-
As folic acid (used in many supplements and food fortification)
-
As methylfolate (also called 5-MTHF, the biologically active form, which is also found in many supplements)
All of these contribute to your body’s folate status (in other words, how much usable folate your body has available to support things like cell growth, DNA production and early development).
What is folic acid?
Folic acid is a synthetic form of folate that has been used for decades in supplements and fortified foods.
Once consumed, folic acid must be converted through a series of metabolic steps into its active form (5-MTHF or 5-methyltetrahydrofolate) before your body can use it in DNA synthesis, cell division, and other critical functions.
Folic acid is stable, easy to measure accurately, and well-studied, which is why governments and governing health organisations around the world choose it for public health programs. Most importantly, folic acid has the strongest evidence for preventing certain birth defects at the population level.
What is methylfolate?
Methylfolate is the bioactive form of folate that cells actually use. Biologically, it performs the same roles as the converted form of folic acid (supporting DNA synthesis, methylation reactions and cell division), but it bypasses several conversion steps required by folic acid.
While methylfolate occurs naturally in foods and is available in supplements, it is still manufactured synthetically for use in prenatal products, just like folic acid. The difference lies in where it enters the metabolism pathway. Methylfolate enters as the active form, whereas folic acid must be processed into that form in the body.
This distinction matters when considering genetic variation in folate metabolism, but it does not inherently make methylfolate superior for all outcomes.
What is MTHFR, and why does it come up so often?
MTHFR (methylenetetrahydrofolate reductase) is a gene that makes an enzyme important for processing folate (vitamin B9) in the body.
Some people have variations in this gene, called MTHFR variants, that make the enzyme work less efficiently. This can affect how their body converts folic acid into the active form of folate.
Studies suggest people with these variants still get enough folate if they take recommended supplement doses (400 mcg/day), but methylfolate supplements are sometimes chosen because they deliver the active form directly, bypassing the enzyme step.
MTHFR variants are relatively common:
-
Homozygous C677T variant (two copies) occurs in roughly 1% of African Americans, 10% of Caucasians and Asians, and 25% of Hispanics. People with this variant may have around 60–70% lower enzyme activity, meaning their bodies process folic acid less efficiently.
-
Heterozygous C677T carriers (one copy) are much more common, estimated at 30–50% of the population, and typically have 30–35% lower enzyme activity.
-
Other variants, such as A1298C, usually have a smaller effect, with up to 20–40% reduced enzyme activity when present in two copies.
What does the evidence say about methylfolate vs folic acid for MTHFR?
-
Biochemical studies show that methylfolate can raise blood folate levels effectively, including in individuals with MTHFR variants.
-
However, raised folate levels alone are not sufficient to prevent neural tube defects, and cases of NTDs have been reported even in women with adequate or high folate status. This highlights that neural tube closure is influenced by multiple factors, including timing of exposure and underlying maternal risk factors.
-
Importantly, there are currently no large population-based trials demonstrating that methylfolate supplementation reduces the risk of neural tube defects or other pregnancy outcomes compared with folic acid. As a result, the strongest clinical and public-health evidence for NTD prevention remains based on folic acid supplementation, particularly when taken before conception and in early pregnancy (Crider et al., 2011; Bailey & Berry, 2005).
What about unmetabolised folic acid (UMFA)?
UMFA refers to folic acid in the bloodstream that hasn’t yet been converted to active folate. Some online sources suggest it is harmful, but current research has not shown consistent adverse health outcomes from UMFA at standard supplement doses (400 mcg/day). (Pfeiffer et al., 2015)
Population-level studies and public health guidelines continue to recommend folic acid safely because the benefits, especially NTD prevention, outweigh any theoretical risks.
In short:
-
Methylfolate is biologically active and may be preferred by some people with MTHFR variants.
-
Folic acid remains the form with proven outcomes for neural tube defect prevention.
-
Concerns about unmetabolised folic acid are theoretical at standard doses, and there is no evidence it outweighs the benefits of folic acid supplementation in pregnancy.
Folic Acid and Neural Tube Defects: The Evidence
The link between folic acid and neural tube defect (NTD) prevention is one of the most robust nutritional findings in pregnancy research:
-
Multiple clinical trials and large cohort studies show that supplementation with folic acid before and during early pregnancy significantly reduces the occurrence and recurrence of NTDs.
-
A Cochrane review of studies involving folic acid supplementation (0.36 mg to 4 mg daily) found a clear protective effect against NTDs but insufficient evidence to conclude benefits for other birth defects.
-
In Australia, mandatory fortification of bread flour with folic acid was followed by a significant overall decrease in NTDs, including a ~55 % decrease among teenage mothers and a ~74 % decrease among Aboriginal and Torres Strait Islander women (aihw.gov.au)
Importantly: folic acid is the only form of supplemental folate that has been repeatedly shown in clinical trials to prevent neural tube defects. While methylfolate does raise blood folate levels, no large clinical trials have yet shown that methylfolate supplementation prevents NTDs specifically (not because it is known to be inferior, but because those trials have simply not been done!).
What Public Health Authorities Recommend (and Why)
International guidelines recommend folate supplementation based on strong evidence, particularly for preventing neural tube defects.
Recommended Amounts (mcg):
-
At least 400 mcg of folic acid daily for people planning pregnancy, starting at least one month before conception and continuing through the first trimester.
-
Higher doses (e.g., 4 mg/4,000 mcg daily) are sometimes recommended for people with a history of a neural tube defect (NTD) or other identified risk factors.
-
Some evidence supports beginning supplementation even three months before conception for optimal preconception health.
These recommendations refer specifically to supplemental folic acid because the clinical trial evidence showing reduced neural tube defect risk has been conducted using this form.
These recommendations come from major public health bodies including the Australian Pregnancy Care Guidelines, The Royal Australian College of General Practitioners (RACGP) the National Health and Medical Research Council (NHMRC), the World Health Organisation (WHO) and numerous national obstetrical organisations, based on decades of research showing that folic acid reduces NTD risk.
Why folic acid during preconception? Because the neural tube closes by about day 28 after conception, often before many women realise they are pregnant, so folate must be established early.
Key Trials & Studies
Here are some of the major research efforts that underpin the evidence base:
-
Cochrane periconceptional folic acid review (multiple RCTs, ~6,000+ pregnancies): protective effect on NTDs with folic acid vs placebo across diverse populations.
-
Blencowe et al. pooled analyses (~6,700 births): consistent NTD reduction with folic acid supplementation across dose ranges.
-
FASSTT Randomised Trial & 11-year follow-up: continued folic acid into 2nd/3rd trimester associated with improved child neurocognitive performance.
-
Systematic reviews on birth outcomes (~700+ participants): higher total folate intake linked with increases in birthweight.
Is one form “better” than the other?
This is where a lot of online debate becomes misleading. We support informed choice, not ideology. We know, this article goes pretty deep, but in summary the evidence shows:
-
Folic acid has the strongest human trial evidence showing it reduces neural tube defect risk when taken periconceptionally at recommended doses.
-
Both folic acid and methylfolate raise active folate levels and support the same biological functions once in the body.
-
Evidence for broader outcomes like cognitive development and maternal health is growing for both, but not yet definitive.
-
Choice of folate form should be based on personal context and preferences, not simplistic “this vs that” arguments.
At Mother Natal, we stand for neutral, evidence-led choice, because every pregnancy journey is different, and every parent deserves accurate, science-based information without bias. That's why we are the first brand globally to offer a dual-folate range of prenatals:
Complete Support - with the recommended 400 mcg folic acid + 100 mcg methylfolate = total folate 500 mcg per daily dose
Complete Support Sensitive - with 500 mcg methylfolate (purposefully folic-acid free) = total folate 500 mcg per daily dose
FAQs
Is folic acid bad for you?
No. Folic acid in its recommended dose has been used safely for decades and is associated with reduced risk of neural tube defects at a population level.
Is methylfolate more “natural”?
No. Both folic acid and methylfolate in supplements are synthetically produced. “Natural” vs “synthetic” can sometimes be used as a marketing trap, but inherently it doesn’t tell us whether a nutrient works better; what matters is how the body uses it.
If I have MTHFR, should I avoid folic acid?
Not necessarily. Many people with MTHFR variants still maintain adequate folate levels with folic acid. Some may prefer methylfolate, but this is best decided with a healthcare provider.
Can you mix folic acid and methylfolate?
Yes. Some prenatal formulas, including our Complete Support, include both forms to support different metabolic pathways.
Does food folate count?
Yes, but it is more difficult to reach pregnancy requirements through food alone, and due to the importance of folate in pregnancy, supplementation is recommended in addition to a healthy diet rich in dark leafy greens, legumes and other key folate sources.
References
World Health Organization (WHO). Periconceptional folate supplementation to prevent neural tube defects. https://www.who.int/tools/elena/interventions/folate-periconceptional
De-Regil LM, Peña-Rosas JP, Fernández-Gaxiola AC, Rayco-Solon P. Effects and safety of periconceptional oral folate supplementation for preventing birth defects. Cochrane Database of Systematic Reviews 2015, Issue 12. Art. No.: CD007950. DOI: 10.1002/14651858.CD007950.pub3.
Centers for Disease Control and Prevention (CDC). Folic Acid: Clinical Overview and MTHFR. https://www.cdc.gov/folic-acid/data-research/mthfr/index.html
H Blencowe., S Cousens., B Modell., J Lawn. Folic acid to reduce neonatal mortality from neural tube disorders. International Journal of Epidemiology, Volume 39, Issue suppl_1, April 2010, Pages i110–i121. https://doi.org/10.1093/ije/dyq028
McNulty H, Rollins M, Cassidy T, Caffrey A, Marshall B, Dornan J, McLaughlin M, McNulty BA, Ward M, Strain JJ, Molloy AM, Lees-Murdock DJ, Walsh CP, Pentieva K. Effect of continued folic acid supplementation beyond the first trimester of pregnancy on cognitive performance in the child: a follow-up study from a randomized controlled trial (FASSTT Offspring Trial). BMC Med. 2019 Oct 31;17(1):196. https://pmc.ncbi.nlm.nih.gov/articles/PMC6823954/
Bailey LB, Berry RJ. Folate and Neural Tube Defects: Epidemiology and Genetics. American Journal of Clinical Nutrition, 2005. https://www.sciencedirect.com/science/article/pii/S0002916523282118
Scaglione F, Panzavolta G. Folate, folic acid and 5-methyltetrahydrofolate are not the same thing. Xenobiotica. 2014 May;44(5):480-8. doi: 10.3109/00498254.2013.845705. Epub 2014 Feb 4. PMID: 24494987. https://pubmed.ncbi.nlm.nih.gov/24494987/
Ferrazzi E, Tiso G, Di Martino D. Folic acid versus 5- methyl tetrahydrofolate supplementation in pregnancy. European Journal Obstetric Gynecol Reprod Biol. 2020 Oct;253:312-319. doi: 10.1016/j.ejogrb.2020.06.012. Epub 2020 Jun 13. PMID: 32868164. https://pubmed.ncbi.nlm.nih.gov/32868164/
NIH: Folate Factsheet. https://ods.od.nih.gov/factsheets/Folate-HealthProfessional/
Australian Government. Pregnancy Care Guidelines. https://app.magicapp.org/?language=bo#/guideline/jm83RE
RACPG: Reproductive and women’s health | Preconception. https://www.racgp.org.au/clinical-resources/clinical-guidelines/key-racgp-guidelines/view-all-racgp-guidelines/preventive-activities-in-general-practice/reproductive-and-womens-health/preconception
Crider, K. S., Bailey, L. B., & Berry, R. J. (2011). Folic Acid Food Fortification—Its History, Effect, Concerns, and Future Directions. Nutrients, 3(3), 370-384. https://doi.org/10.3390/nu3030370